IL151131A0 - Improved galactosylation of recombinant glycoproteins - Google Patents

Improved galactosylation of recombinant glycoproteins

Info

Publication number
IL151131A0
IL151131A0 IL15113101A IL15113101A IL151131A0 IL 151131 A0 IL151131 A0 IL 151131A0 IL 15113101 A IL15113101 A IL 15113101A IL 15113101 A IL15113101 A IL 15113101A IL 151131 A0 IL151131 A0 IL 151131A0
Authority
IL
Israel
Prior art keywords
recombinant glycoproteins
galactosylation
improved
improved galactosylation
enhanced
Prior art date
Application number
IL15113101A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL151131A0 publication Critical patent/IL151131A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
IL15113101A 2000-02-08 2001-02-07 Improved galactosylation of recombinant glycoproteins IL151131A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18110800P 2000-02-08 2000-02-08
US19164100P 2000-03-23 2000-03-23
PCT/US2001/003945 WO2001059089A2 (fr) 2000-02-08 2001-02-07 Amelioration de la galactosylation de glycoproteines de recombinaison

Publications (1)

Publication Number Publication Date
IL151131A0 true IL151131A0 (en) 2003-04-10

Family

ID=26876894

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15113101A IL151131A0 (en) 2000-02-08 2001-02-07 Improved galactosylation of recombinant glycoproteins

Country Status (10)

Country Link
US (2) US20030211573A1 (fr)
EP (1) EP1254216B1 (fr)
JP (1) JP2003521942A (fr)
AT (1) ATE329018T1 (fr)
AU (1) AU783973B2 (fr)
CA (1) CA2399266A1 (fr)
DE (1) DE60120356T2 (fr)
ES (1) ES2266159T3 (fr)
IL (1) IL151131A0 (fr)
WO (1) WO2001059089A2 (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2354610T5 (es) 2002-12-23 2020-09-14 Bristol Myers Squibb Co Mejora de la calidad del producto en procedimientos de cultivo de células de mamífero para la producción de proteína
KR101412271B1 (ko) * 2003-05-09 2014-06-25 듀크 유니버시티 Ｃｄ２０-특이적 항체 및 이를 이용한 방법
AU2007294731B2 (en) 2006-09-13 2014-04-17 Abbvie Inc. Cell culture improvements
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
US7873748B2 (en) * 2007-11-30 2011-01-18 International Business Machines Corporation Synchronization of locally and remotely stored browser data
NZ592097A (en) 2008-10-20 2013-01-25 Abbott Lab Viral inactivation during purification of il-12 and il-18 antibodies
CA2911256A1 (fr) * 2008-10-20 2010-12-09 Robert K. Hickman Isolement et purification d'anticorps par chromatographie d'affinite de la proteine a
EP2435577A4 (fr) * 2009-05-26 2016-04-13 Momenta Pharmaceuticals Inc Production de glycoprotéines
MX2012011648A (es) 2010-04-07 2012-11-29 Momenta Pharmaceuticals Inc Glicanos de alta manosa.
EP2686671A4 (fr) 2011-03-12 2015-06-24 Momenta Pharmaceuticals Inc N-glycanes contenant de la n-acétylhexosamine dans des produits de glycoprotéines
WO2012149197A2 (fr) 2011-04-27 2012-11-01 Abbott Laboratories Procédé de contrôle du profil de galactosylation de protéines exprimées de manière recombinante
WO2013158273A1 (fr) 2012-04-20 2013-10-24 Abbvie Inc. Procédés de modulation de la distribution de variant de lysine c-terminal
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
WO2013176754A1 (fr) 2012-05-24 2013-11-28 Abbvie Inc. Nouvelle purification d'anticorps au moyen de chromatographie à interaction hydrophobe
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
KR20150043523A (ko) 2012-09-02 2015-04-22 애브비 인코포레이티드 단백질 불균일성의 제어 방법
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014159579A1 (fr) 2013-03-14 2014-10-02 Abbvie Inc. Anticorps anti-tnfα ayant mutés et leurs procédés d'utilisation
WO2014151878A2 (fr) 2013-03-14 2014-09-25 Abbvie Inc. Procédés pour la modulation des profils de glycosylation de protéines de traitements à base de protéines recombinantes au moyen de monosaccharides et d'oligosaccharides
WO2014170866A2 (fr) * 2013-04-18 2014-10-23 Dr. Reddy's Laboratories Limited Procédé d'obtention d'une composition glycoprotéique ayant une teneur accrue en galactosylation
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
WO2015073884A2 (fr) 2013-11-15 2015-05-21 Abbvie, Inc. Compositions de protéines de liaison génétiquement glycomodifiées
JP6797458B2 (ja) * 2014-01-29 2020-12-09 エルジー・ケム・リミテッド 培養培地の最適化により組換えタンパク質のガラクトシル化を調節する方法
KR101660580B1 (ko) * 2014-04-02 2016-09-28 프레스티지 바이오파마 피티이. 엘티디. 항체의 당 함량 조절을 통한 항체의 제조 방법
JP6652334B2 (ja) 2014-05-31 2020-02-19 Ｊｃｒファーマ株式会社 ウリジンとｎ−アセチル−ｄ−マンノサミンとを含有する培地

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010260A1 (fr) * 1991-11-21 1993-05-27 The Board Of Trustees Of The Leland Stanford Junior University Utilisation de la neuraminidase extracellulaire pour lutter contre la degradation d'oligosaccharides de la glycoproteine
AU773845B2 (en) * 1998-11-18 2004-06-10 Neose Technologies, Inc. Low cost manufacture of oligosaccharides
US6949372B2 (en) * 1999-03-02 2005-09-27 The Johns Hopkins University Engineering intracellular sialylation pathways
WO2001014569A2 (fr) * 1999-08-20 2001-03-01 Basf Plant Science Gmbh Augmentation de la teneur en polysaccharides dans des plantes

Also Published As

Publication number Publication date
US20030211573A1 (en) 2003-11-13
JP2003521942A (ja) 2003-07-22
DE60120356D1 (de) 2006-07-20
AU3490301A (en) 2001-08-20
EP1254216A2 (fr) 2002-11-06
US20070111284A1 (en) 2007-05-17
ATE329018T1 (de) 2006-06-15
WO2001059089A3 (fr) 2002-07-04
WO2001059089A2 (fr) 2001-08-16
AU783973B2 (en) 2006-01-12
DE60120356T2 (de) 2007-06-14
EP1254216B1 (fr) 2006-06-07
CA2399266A1 (fr) 2001-08-16
ES2266159T3 (es) 2007-03-01

Similar Documents

Publication Publication Date Title
IL151131A0 (en) Improved galactosylation of recombinant glycoproteins
AU2003287324A8 (en) Gene expression systems and recombinant cell lines
HUP0102800A2 (hu) A fitáz gének túlexpresszálása élesztőrendszerekben
MXPA02004666A (es) Gelatinas recombinantes.
GB2368204B (en) Computer system and scanners therefor
HK1091228A1 (en) Methods for making recombinant proteins using apoptosis inhibitors
EA004789B9 (ru) Полимерные конъюгаты бета-1а-интерферона и их использование
IS5449A (is) Umbreytt K-vítamín-háð fjölpeptíð
MXPA02000845A (es) Diseno geometrico y sistema de modelado utilizando geometria de control.
AU2002359779A1 (en) Implantation for current confinement in nitride-based vertical optoelectronics
AU2003201727A1 (en) Recombinant protein expression
PL363181A1 (en) Modified interferon alpha with reduced immunogenicity
AU4257599A (en) Promoter and constructions for expression of recombinant proteins in filamentousfungi
HK1046911A1 (zh) 經穩定的病毒外膜蛋白質及其使用
AU2001256404A1 (en) Novel plant glucosidase i and use thereof for producing recombinant proteins with modified glycosylation
AU2002336744A1 (en) Gene expression control system and its use in recombinant virus packaging cell lines
MX250271B (es) Expresion de proteinas en hongos geneticamente modificados.
AU2001237667A1 (en) A system to control the expression of a given gene using another gene that encodes a polypeptide with recombinant activity
IL146128A0 (en) Expression of heparin-binding protein in recombinant mammalian cells
EP1458736A4 (fr) Thrombine bovine de recombinaison
AU2232399A (en) Recombinant ctb-based vaccines
EP1421119A4 (fr) Cellulose de feuillu modifiee a l'oxyde d'alcoylene
AU2002356339A8 (en) Soluble recombinant protein production
HK1042651A1 (en) Lak activity potentiator orginating in shiitake mushroom hyphae extract and lak activity potentiating preparations containing the same.
IL143771A0 (en) Production of recombinant monellin using methylotrophic yeast expression system